Article
Variation in topoisomerase I gene copy number as a mechanism for intrinsic drug sensitivity.
British journal of cancer - 1 Aug 1996
McLeod H L, Keith W N
Abstract excerpt
DNA topoisomerase I (topo I) is the principle target for camptothecin and its derivatives such as SN38. Levels of topo I expression vary widely between and within tumour types and the basis for this is poorly understood. We have used fluorescence in situ hybridisation to detect the topo I locus in a panel of breast and colon cancer cell lines. This approach has identified a range of topo I gene copies from 1 to 6...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
